Is topiramate effective for migraine prevention in patients less than 18 years of age? A meta-analysis of randomized controlled trials.

Topiramate may not achieve a more effective clinical trial endpoint than placebo in the prevention of migraines in patients less than 18 years of age, and topiramate may lead to more side effects or adverse events in the included patients.